Agere Pharmaceuticals

Agere Pharmaceuticals Overview

Founded 2008
Founded
Status Acquired/​Merged
Employees 53
Employees
Latest Deal Type M&A
Financing Rounds 1

Agere Pharmaceuticals General Information

Description

Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company specializes in improving the oral bioavailability of BCS II - IV compounds through fundamental science, solubilization expertise, and proprietary solubilization technologies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 62925 NorthEast 18th Street
  • Bend, OR 97701
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Agere Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Agere Pharmaceuticals‘s full profile, request access.

Request a free trial

Agere Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Ziopharm Oncology Corporation Boston, MA 00 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000

Agere Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Marshall Crew Ph.D President & Chief Executive Officer
Casey Jones Vice President, Corporate Development
Michael Deperro Vice President, Operations